AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3%
Thu, 21 May

AJANTA PHARMA has announced its results for the quarter ended March 2020. Here is a detailed performance review of the same:

AJANTA PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-19*
3
Dec-19*
3
Mar-20*
QoQ ChangeYoY Change
Net SalesRs m5,1526,5126,8204.7%32.4%
Other incomeRs m16146567287.2%3377.9%
TurnoverRs m5,1686,6597,38710.9%42.9%
ExpensesRs m3,8814,6525,30614.1%36.7%
Gross profitRs m1,2711,8561,488-19.8%17.1%
DepreciationRs m18823626010.3%38.9%
InterestRs m81636130.6%370.1%
Profit before taxRs m1,0921,7511,7590.4%61.1%
TaxRs m203676467-30.9%130.0%
Profit after taxRs m8891,0761,29220.1%45.3%
Gross profit margin%24.728.521.8
Effective tax rate%18.638.626.6
Net profit margin%17.216.217.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 32.4% on a year-on-year (YoY) basis. The expenses were up by 36.7% YoY during the same period.
  • The company's operating profit increased by 17.1% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 21.8% in 4QFY20 as against 24.7% in 4QFY19.
  • Depreciation charges increased by 38.9% and finance costs increased by 370.1% YoY, respectively.
  • Other income increased by 3377.9% YoY during the quarter.
  • Net profit for the quarter increased by 45.3% YoY. Net profit margins during the quarter increased from 17.2% in 4QFY19 to 17.5% in 4QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 4.7% on a quarter-on-quarter (QoQ) basis. The expenses were up by 14.1% QoQ during the same period.
  • The company's operating profit declined by 19.8% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 21.8% in 4QFY20 as against 28.5% in 3QFY19.
  • Net profit for the quarter increased by 20.1% QoQ, while net profit margins increased from 16.2% in 3QFY19 to 17.5% in 4QFY20.

To see how AJANTA PHARMA has performed over the last eight quarters,please visit here.

AJANTA PHARMA Share Price Performance

Over the last one year,AJANTA PHARMA share price has moved up from Rs 1,014.7 to Rs 1,483.1, registering a Gain of Rs 468.4 or around 46.2%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 15,446.5 (up 0.6%). Over the last one year it has moved up from 13,260.3 to 15,446.5, a gain of 2,186 points (up 16.5%).

Overall, the S&P BSE SENSEX is down 21.1% over the year.

Current Valuations

At the current price of Rs 1,483.1, the price to earnings (P/E) ratio of AJANTA PHARMA stands at 27.9 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 5.8 times.

Equitymaster requests your view! Post a comment on "AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3%". Click here!

  

Related Views on News

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Feb 26, 2021 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA - NOVARTIS COMPARISON

COMPARE AJANTA PHARMA WITH

MARKET STATS